191 related articles for article (PubMed ID: 6371237)
1. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
3. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
[TBL] [Abstract][Full Text] [Related]
4. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
5. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
Sorg C; Geczy CL
Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
[TBL] [Abstract][Full Text] [Related]
8. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
9. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
11. Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
Jyonouchi H; Kimmel MD; Lee G; Kincade PW; Good RA
J Immunol; 1985 Sep; 135(3):1891-9. PubMed ID: 3926891
[TBL] [Abstract][Full Text] [Related]
12. Production of MIF-like supernatants by rheumatoid arthritis lymphocytes stimulated by immunoglobulin G.
Sany J; Mathieu O; Clot J; Mandin J; Serre H
Rheumatology; 1975; 6():131-8. PubMed ID: 1105742
[TBL] [Abstract][Full Text] [Related]
13. Studies on human migration inhibitory factor: characterization of three molecular species.
Weiser WY; Greineder DK; Remold HG; David JR
J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
[TBL] [Abstract][Full Text] [Related]
14. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
Ruthlomnitzer ; Rabson AR; Koornhof HJ
Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
[TBL] [Abstract][Full Text] [Related]
15. Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor.
Osada H; Furukawa-Nakanishi K; Miyamoto D; Kobayashi Y; Osawa T
Lymphokine Res; 1989; 8(4):393-405. PubMed ID: 2509820
[TBL] [Abstract][Full Text] [Related]
16. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
Scott DM; McConnell I; Agomo P; Lachmann PJ
Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
[TBL] [Abstract][Full Text] [Related]
17. Studies on guinea-pig macrophage migration inhibitory factor (MIF). II. Purification of MIF after treatment with reducing and denaturing agents.
Kotkes P; Pick E
Clin Exp Immunol; 1979 Sep; 37(3):540-50. PubMed ID: 389497
[TBL] [Abstract][Full Text] [Related]
18. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
[TBL] [Abstract][Full Text] [Related]
19. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
20. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
Greineder DK; Rocklin RE; David JR
J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
